Nonalcoholic fatty liver disease: The hepatic metabolic syndrome

Journal of the American Academy of Nurse Practitioners

Volumn 24, Issue 6, 2012, Pages 345-351

  Page, Jeni ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Gastroenterology; Hepatomegaly; Insulin resistance; Liver; Metabolic syndrome; Obesity

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; RISK FACTOR;

ADULT; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 84861920191     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2012.00716.x     Document Type: Article

References (40)

1. Bacon, B. R. & Britton, R. S. (2003). Hemochromatosis and other iron storage disorders. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 2, pp. 1170-1186). Philadelphia, PA: Lippincott Williams & Wilkins.
2. Brunt, E. M. (2010). Pathology of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology, 7(4), 195-203. doi:.
3. Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005). Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology, 42(5), 987-1000. doi:.
4. Cheung, O. & Sanyal, A. J. (2010). Recent advances in nonalcoholic fatty liver disease. Current Opinion in Gastroenterology, 26(3), 202-208. doi:.
5. Chitturi, S. & Farrell, G. C. (2003). Drug-induced liver disease. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 2, pp. 1059-1127). Philadelphia, PA: Lippincott Williams & Wilkins.
6. Choudhury, J. & Sanyal, A. J. (2004). Clinical aspects of fatty liver disease. Seminars in Liver Disease, 24(4), 349-362. doi:.
7. Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. American Journal of Gastroenterology, 98(5), 960-967. doi:.
8. Davis, G.L. (2003). Hepatitis C. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 808-861). Philadelphia, PA: Lippincott Williams & Wilkins.
9. Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brian, P. E. (2004). Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology, 39(6), 1647-1654. doi:.
10. Fabbrini, E., Conte, C., & Magkos, F. (2009). Methods for assessing intrahepatic fat content and steatosis. Current Opinion in Clinical Nutrition & Metabolic Care, 12(5), 474-481. doi:.
11. Gastaldelli, A., Kozakova, M., Højlund, K., Flyvbjerg, A., Favuzzi, A., Mitrakou, A., The RISC Investigators. (2009). Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology, 49(5), 1537-1544. doi:.
12. Heathcote, E. J. (2003). Primary biliary cirrhosis. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 702-712). Philadelphia, PA: Lippincott Williams & Wilkins.
13. Kadayifci, A., Merriman, R. B., & Bass, N. M. (2007). Medical treatment of non-alcoholic steatohepatitis. Clinics in Liver Disease, 11(1), 119-140. doi:.
14. Kapoor, S. (2010). Diagnosis and treatment of acanthosis nigricans. Skinmed, 8(3), 161-164. Retrieved from.
15. Krawitt, E. L. (2008). Clinical features and management of autoimmune hepatitis. World Journal of Gastroenterology, 14(21), 3301-3305. doi:.
16. Lemon, S. M. & Martin, A. (2003). Hepatitis A. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 745-762). Philadelphia, PA: Lippincott Williams & Wilkins.
17. Lindor, K. D. & Larusso, N. F. (2003). Primary sclerosing cholangitis. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 673-684). Philadelphia, PA: Lippincott Williams & Wilkins.
18. Lok, A. S. F. & Conjeevaram, H. S. (2003). Hepatitis B. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 764-806). Philadelphia, PA: Lippincott Williams & Wilkins.
19. Marrero, J. A. & Welling, T. (2009). Modern diagnosis and management of hepatocellular carcinoma. Clinics in Liver Disease, 13(2), 233-247. doi:.
20. McCullough, A. J. (2004). The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clinics in Liver Disease, 8(3), 521-533. doi:.
21. Ogden, C. L., Carroll, M. D., McDowell, M. A., & Flegal, K. M. (2006). Obesity among adults in the United States-No statistically significant change since 2003-2004, Data Brief No. 1. 2006. Hyattsville, MD: National Center for Health Statistics.
22. Ong, J. P. & Younossi, Z. M. (2007). Epidemiology and natural history of NAFLD and NASH. Clinics in Liver Disease, 11(1), 1-16. doi:.
23. Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Rizzetto, M. (2002). Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology, 35(2), 367-372. doi:.
24. Perlmutter, D. H. (2003). α1-antitrypsin deficiency. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 2, pp. 1207-1229). Philadelphia, PA: Lippincott Williams & Wilkins.
25. Perlmutter, D. H. (2004). Alpha-1-antitrypsin deficiency: Diagnosis and treatment. Clinics in Liver Disease, 8(4), 839-859. doi:.
26. Pratt, D.S. & Kaplan, M.M. (2003). Evaluation of the liver: Laboratory tests. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds.), Schiff's diseases of the liver (Vol. 1, pp. 221-255). Philadelphia, PA: Lippincott Williams & Wilkins.
27. Promrat, K., Kleiner, D.E., Neimeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., Wing, R. R. (2010). Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology, 51(1), 121-129. doi:.
28. Rafiq, N., Chunhong, B., Fang, Y, - F., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z.M. (2009). Long-term follow-up of patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 7(2), 234-238. doi:.
29. Rafiq, N. & Younossi, Z. M. (2009). Nonalcoholic fatty liver disease: A practical approach to evaluation and management. Clinics of Liver Disease, 13(2), 249-266. doi:.
30. Sanyal, A. J. (2002). AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 123(5), 1705-1725. doi:.
31. Sanyal, A.J., Chalasani, N., Kowdley, K.V., McCullough, A., Diehl, A. M., Bass, N. M., Robuck, P. R. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England Journal of Medicine, 362(18), 1675-1685. doi:.
32. Sargent, S. (2006). Management of patients with advanced liver cirrhosis. Nursing Standard, 21(11), 48-56. Retrieved from.
33. Schilsky, M., & Tavill, A. S. (2003). Wilson disease. In E. R. Schiff, M. F. Sorrell, & W. C. Maddrey (Eds S.), Schiff's diseases of the liver, (Vol. 2, pp. 1169-1186). Philadelphia, PA: Lippincott Williams & Wilkins.
34. Shaked, O. & Reddy, K. R. (2009). Approach to a liver mass. Clinics in Liver Disease, 13(2), 193-210. doi:.
35. Sharp, D. B., Santos, L. A., & Cruz, M. L. (2009). Fatty liver in adolescents on the U.S.-Mexico border. Journal of the American Academy of Nurse Practitioners, 21, 225-230. doi:.
36. Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010). Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology, 51(5), 1820-1832. doi:.
37. Tiniakos, D. G. (2010). Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: Histological diagnostic criteria and scoring system. European Journal of Gastroenterology & Hepatology, 22(6), 643-650. doi:.
38. Weston, S. R., Leyden, W., Murphy, R., Bass, N. M., Bell, B. P., Manos, M. M., & Terrault, N. A. (2005). Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology, 41(2), 372-379. doi:.
39. Whitt, K. N., Ward, S. C., Deniz, K., Liu, L., Odin, J. A., & Qin, L. (2008). Cholestatic liver injury associated with whey protein and creatine supplements. Seminars in Liver Disease, 28(2), 226-232. doi:.
40. Wood, N. J. (2010). Obesity: Update on the prevalence of high BMI and obesity in the USA. Nature Reviews Gastroenterology & Hepatology, 7(4), 182. doi:.